|
Volumn 35, Issue 2 Suppl, 2008, Pages
|
Improved patient outcomes in chronic kidney disease: optimizing vitamin D therapy.
a
a
USA
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1 ALPHA HYDROXYERGOCALCIFEROL;
1 ALPHA-HYDROXYERGOCALCIFEROL;
CALCITRIOL;
CINACALCET;
ERGOCALCIFEROL;
NAPHTHALENE DERIVATIVE;
PARATHYROID HORMONE;
VITAMIN D;
CALCINOSIS;
CARDIOVASCULAR DISEASE;
CHEMISTRY;
CHRONIC KIDNEY FAILURE;
DISEASE COURSE;
DRUG MONITORING;
EPIDEMIOLOGY;
GLOMERULUS FILTRATION RATE;
HOSPITALIZATION;
HUMAN;
HYPERPHOSPHATEMIA;
MORTALITY;
NURSE ATTITUDE;
PATHOLOGY;
PERIPHERAL OCCLUSIVE ARTERY DISEASE;
PHOSPHATE INTAKE;
PHYSIOLOGY;
PROPORTIONAL HAZARDS MODEL;
REVIEW;
SECONDARY HYPERPARATHYROIDISM;
TREATMENT OUTCOME;
VITAMIN D DEFICIENCY;
ARTERIAL OCCLUSIVE DISEASES;
CALCINOSIS;
CALCITRIOL;
CARDIOVASCULAR DISEASES;
CAUSALITY;
DISEASE PROGRESSION;
DRUG MONITORING;
ERGOCALCIFEROLS;
GLOMERULAR FILTRATION RATE;
HUMANS;
HYPERPARATHYROIDISM, SECONDARY;
HYPERPHOSPHATEMIA;
KIDNEY FAILURE, CHRONIC;
NAPHTHALENES;
NURSE'S ROLE;
PARATHYROID HORMONE;
PHOSPHORUS, DIETARY;
PROPORTIONAL HAZARDS MODELS;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
VITAMIN D;
VITAMIN D DEFICIENCY;
|
EID: 46749103314
PISSN: 1526744X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (96)
|